Cargando…

Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India

Neurofibromatosis type 1 (NF1) is a multisystemic hereditary disorder associated with an increased risk of benign and malignant tumor formation predominantly on the skin, bone, and peripheral nervous system. It has been reported that out of all the NF1 cases, more than 95% cases develop the disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Spolia, Akshi, Angural, Arshia, Sharma, Varun, Shipra, Razdan, Sushil, Dhar, Manoj K., Mahajan, Ankit, Verma, Vijeshwar, Pandita, Kamal K., Sharma, Swarkar, Rai, Ekta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185681/
https://www.ncbi.nlm.nih.gov/pubmed/37188759
http://dx.doi.org/10.1038/s41598-023-34941-y
_version_ 1785042409580658688
author Spolia, Akshi
Angural, Arshia
Sharma, Varun
Shipra
Razdan, Sushil
Dhar, Manoj K.
Mahajan, Ankit
Verma, Vijeshwar
Pandita, Kamal K.
Sharma, Swarkar
Rai, Ekta
author_facet Spolia, Akshi
Angural, Arshia
Sharma, Varun
Shipra
Razdan, Sushil
Dhar, Manoj K.
Mahajan, Ankit
Verma, Vijeshwar
Pandita, Kamal K.
Sharma, Swarkar
Rai, Ekta
author_sort Spolia, Akshi
collection PubMed
description Neurofibromatosis type 1 (NF1) is a multisystemic hereditary disorder associated with an increased risk of benign and malignant tumor formation predominantly on the skin, bone, and peripheral nervous system. It has been reported that out of all the NF1 cases, more than 95% cases develop the disease due to heterozygous loss-of-function variants in Neurofibromin (NF1) gene. However, identification of NF1 causative variants by presently recommended method of gene-targeted Sanger sequencing is challenging and cost-intensive due to the large size of the NF1gene with 60 exons spanning about 350 kb. Further, conducting the genetic studies is difficult in low resource regions and among families with the limited financial capabilities, restricting them from availing diagnostic as well as proper disease management measures. Here, we studied a three-generation family from Jammu and Kashmir state in India, with multiple affected family members showing clinical indications of NF1. We combinedly used two applications, Whole Exome Sequencing (WES) and Sanger sequencing, for this study and discovered a nonsense variant NM_000267.3:c.2041C>T (NP_000258.1:p.Arg681Ter*) in exon 18 of NF1 gene in a cost effective manner. In silico analyses further substantiated the pathogenicity of this novel variant. The study also emphasized on the role of Next Generation Sequencing (NGS) as a cost-effective method for the discovery of pathogenic variants in disorders with known phenotypes found in large sized candidate genes. The current study is the first study based on the genetic characterization of NF1 from Jammu and Kashmir–India, highlighting the importance of the described methodology adopted for the identification and understanding of the disease in low resource region. The early diagnosis of genetic disorders would open the door to appropriate genetic counseling, reducing the disease burden in the affected families and the general population at large.
format Online
Article
Text
id pubmed-10185681
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101856812023-05-17 Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India Spolia, Akshi Angural, Arshia Sharma, Varun Shipra Razdan, Sushil Dhar, Manoj K. Mahajan, Ankit Verma, Vijeshwar Pandita, Kamal K. Sharma, Swarkar Rai, Ekta Sci Rep Article Neurofibromatosis type 1 (NF1) is a multisystemic hereditary disorder associated with an increased risk of benign and malignant tumor formation predominantly on the skin, bone, and peripheral nervous system. It has been reported that out of all the NF1 cases, more than 95% cases develop the disease due to heterozygous loss-of-function variants in Neurofibromin (NF1) gene. However, identification of NF1 causative variants by presently recommended method of gene-targeted Sanger sequencing is challenging and cost-intensive due to the large size of the NF1gene with 60 exons spanning about 350 kb. Further, conducting the genetic studies is difficult in low resource regions and among families with the limited financial capabilities, restricting them from availing diagnostic as well as proper disease management measures. Here, we studied a three-generation family from Jammu and Kashmir state in India, with multiple affected family members showing clinical indications of NF1. We combinedly used two applications, Whole Exome Sequencing (WES) and Sanger sequencing, for this study and discovered a nonsense variant NM_000267.3:c.2041C>T (NP_000258.1:p.Arg681Ter*) in exon 18 of NF1 gene in a cost effective manner. In silico analyses further substantiated the pathogenicity of this novel variant. The study also emphasized on the role of Next Generation Sequencing (NGS) as a cost-effective method for the discovery of pathogenic variants in disorders with known phenotypes found in large sized candidate genes. The current study is the first study based on the genetic characterization of NF1 from Jammu and Kashmir–India, highlighting the importance of the described methodology adopted for the identification and understanding of the disease in low resource region. The early diagnosis of genetic disorders would open the door to appropriate genetic counseling, reducing the disease burden in the affected families and the general population at large. Nature Publishing Group UK 2023-05-15 /pmc/articles/PMC10185681/ /pubmed/37188759 http://dx.doi.org/10.1038/s41598-023-34941-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Spolia, Akshi
Angural, Arshia
Sharma, Varun
Shipra
Razdan, Sushil
Dhar, Manoj K.
Mahajan, Ankit
Verma, Vijeshwar
Pandita, Kamal K.
Sharma, Swarkar
Rai, Ekta
Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title_full Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title_fullStr Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title_full_unstemmed Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title_short Cost-effective Whole Exome Sequencing discovers pathogenic variant causing Neurofibromatosis type 1 in a family from Jammu and Kashmir, India
title_sort cost-effective whole exome sequencing discovers pathogenic variant causing neurofibromatosis type 1 in a family from jammu and kashmir, india
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185681/
https://www.ncbi.nlm.nih.gov/pubmed/37188759
http://dx.doi.org/10.1038/s41598-023-34941-y
work_keys_str_mv AT spoliaakshi costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT anguralarshia costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT sharmavarun costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT shipra costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT razdansushil costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT dharmanojk costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT mahajanankit costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT vermavijeshwar costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT panditakamalk costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT sharmaswarkar costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia
AT raiekta costeffectivewholeexomesequencingdiscoverspathogenicvariantcausingneurofibromatosistype1inafamilyfromjammuandkashmirindia